MAIN

Mediakit 2020

 NEWSPLASTINFO : NEWS
 

SANITIZED AG invests in customer-specific development of antimicrobial masterbatches

 |  Subj: Press-releses

A specially developed twin-screw extruder in the SANITIZED AG TecCenter allows even faster development of new masterbatch combinations and the manufacture of test amounts of polymers with individual antimicrobial additives. This investment especially allows the targeted, customer-specific development of antimicrobial masterbatch qualities in nearly any type of polymer.

The selection of the appropriate antimicrobial active ingredients depends on the defined protection goals, on their compatibility with the relevant processing methods of the semi-finished product suppliers or final customers and/or if they have an impact on the manufacturing procedure. The application testing of the antimicrobial products on the basis of the customer-specific formulations in laboratory quantities on the same processing machines is thus highly beneficial: Time and cost intensive tests on industrial systems are not required. The laboratory becomes a real-life situation.

This is where SANITIZED AG supports its customers. A new twin-screw extruder has begun operating in the TecCenter for processing standard polymers (bulk plastics) as well as technical polymers (engineering plastics). Masterbatches of low to high-melt polymers in different formulations and the finished compound can be manufactured. Two nozzle plates allow the extrusion of polymer strands and tapes for further examination of the antimicrobial effectiveness in the SANITIZED microbiology laboratory.

“Biofilms, fungi, pink stain or hospital pathogens: the protective aims for polymer products are highly individual, as are the production conditions,” explains Renaud Houy, Head of Sales Polymer at SANITIZED AG. “We are helping polymer processors to outline the entire production cycle and to test the antimicrobial efficacy.”

Source: SANITIZED AG

Previous news


© 2002—2024 PLASTINFO